News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Aroa Biosurgery.
RELATED STOCKHEAD STORIES
Director Trades
Directors’ Trades: Resources has been off the boil, but these directors just took a punt on their companies
Health & Biotech
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
Health & Biotech
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
Experts
These ASX stocks were the pick of the bunch at the Pinnacle Investment Summit
Health & Biotech
ScoPo’s Powerplays: Smaller capped health stocks are still in ‘no man’s land’, but Neuren jumps 18pc this week
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
Health & Biotech
New breakthrough in stem cells research paves the way for ASX regenerative medicine stocks
News
Last Orders: ASX returns from Easter break with a gain
News
With America vaccinating 2 million a day, here are 3 ASX medtechs that will benefit as lockdowns are lifted
Experts
ScoPo’s health powerplays: ‘A great start to reporting season for healthcare’
Health & Biotech
Broken bones are no pretty picture but these ASX stocks help you diagnose or fix them
IPO Watch
IPO Watch: Doctor Care Anywhere set to join the ASX telehealth ranks next month
News
Charted: Why fund managers have their eye on these ASX small caps
IPO Watch
The driving forces behind Australia’s red-hot IPO market
News
ASX gold, New Zealand-headquartered small caps take a hit; investors told not to panic
Health & Biotech
